The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested target is unambiguous: human NEK1, encoding NIMA-related serine/threonine-protein kinase 1 (synonym KIAA1901), UniProt Q96PY6. The literature examined consistently concerns this human kinase—not NEK7, NEK8, NEK10, or a nonhuman similarly named protein. Its architecture—an N-terminal protein-kinase domain, central coiled-coil interaction region, and acidic C-terminal region—agrees with the supplied UniProt NEK-family/domain annotation. The acidic C terminus contains a mapped C21ORF2-interaction domain (CID). (gregorczyk2022interactionwithc21orf2 pages 4-7, gregorczyk2023functionalcharacterizationof pages 2-3)
NEK1’s primary molecular function is ATP-dependent phosphorylation of protein serine/threonine residues. Current evidence supports NEK1 as a spatially regulated signaling kinase coordinating primary-cilium/centrosome biology, microtubule organization and nuclear transport, and DNA-damage responses including homologous recombination (HR). It also influences mitochondrial homeostasis, although the proximal mitochondrial substrate pathway is less certain. The strongest recent mechanistic development is identification of C21ORF2 as a tightly associated regulatory partner required, together with NEK1 catalytic activity, for ciliogenesis and HR. A second major 2023 advance linked NEK1 loss in human motor neurons to microtubule and nucleocytoplasmic-transport defects and showed in-vitro phosphorylation of α-tubulin and importin-β1. (gregorczyk2023functionalcharacterizationof pages 8-10, mann2023lossoffunction pages 2-3)
NEK1 belongs to the human never-in-mitosis A-related kinase (NEK) family of serine/threonine kinases. The supplied identity—NEK1/KIAA1901, Homo sapiens, Q96PY6—is consistent with human-cell studies detecting an approximately 141-kDa NEK1 protein. These studies describe an N-terminal Ser/Thr catalytic domain, a central coiled-coil region involved in protein interactions, and a C-terminal acidic region; disease-associated variants occur throughout this architecture. (gregorczyk2022interactionwithc21orf2 pages 4-7, gregorczyk2023functionalcharacterizationof pages 2-3)
The C-terminal region is now functionally resolved in part. NEK1 residues approximately 1160–1286 constitute the C21ORF2-interaction domain; structural modeling places the principal interface around NEK1 residues 1216–1282 and the N-terminal leucine-rich-repeat region of C21ORF2. NEK1-D1277 is predicted to contact C21ORF2-N24, and charge-reversal experiments support extensive electrostatic contacts across this interface. A proposed second interface is lower-confidence and remains to be validated structurally. (gregorczyk2022interactionwithc21orf2 pages 12-14, gregorczyk2022interactionwithc21orf2 pages 9-12)
As a protein serine/threonine kinase, NEK1 catalyzes:
ATP + protein-serine/threonine-OH → ADP + phosphoprotein-serine/threonine.
Its kinase-domain structure supports the canonical ATP-binding and phosphotransfer mechanism of eukaryotic protein kinases. However, a definitive physiological sequence motif or comprehensive endogenous substrate spectrum has not yet been established. Consequently, NEK1 should be annotated as a Ser/Thr protein kinase with context-dependent protein substrates, not as a kinase with a narrowly demonstrated consensus specificity.
TLK1 is reported to bind and phosphorylate NEK1 at T141 in or near its catalytic domain following ionizing radiation or oxidative stress, increasing NEK1 activity and redistribution to γH2AX-positive nuclear foci. Activation-loop phosphorylation/autophosphorylation is also implicated in catalytic regulation. NEK1-D146A is used experimentally as a kinase-dead allele and fails to rescue ciliogenesis, providing direct cellular evidence that catalysis—not merely scaffolding—is essential for that function. (baker2025nekfamilykinases pages 12-13, gregorczyk2023functionalcharacterizationof pages 8-10)
NEK1 is not confined to one organelle. Its localization changes with cellular state:
Accordingly, NEK1 is best classified as a multi-compartment signaling kinase, with experimentally important activity at centrosome–cilium structures, the cytoskeleton/nuclear-transport apparatus, and damage-responsive nuclear complexes.
In human ARPE-19 cells, endogenous NEK1 and C21ORF2 reciprocally co-immunoprecipitated, and the association survived 500 mM NaCl/detergent washes. Similar interaction was observed in HeLa, HEK293, and U2OS cells. Essentially all detectable C21ORF2 appeared NEK1-associated, although a fraction of NEK1 was unbound; interaction proteomics identified the two proteins as one another’s dominant partners. Whether the physical contact is entirely direct remains unresolved. (gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 4-7)
The ALS-associated NEK1-D1277A substitution and engineered interface charge reversals weaken complex formation. NEK1 depletion also lowers C21ORF2 abundance, indicating that NEK1 supports partner stability. Collectively, the authors interpret C21ORF2 as a regulatory subunit of NEK1, rather than merely a transient downstream effector. (gregorczyk2022interactionwithc21orf2 pages 1-4, gregorczyk2022interactionwithc21orf2 pages 9-12)
NEK1 or C21ORF2 knockout dramatically reduced primary-cilium formation after serum starvation in human retinal epithelial cells. Wild-type NEK1 rescued ciliogenesis, but kinase-dead NEK1-D146A and C21ORF2-binding-defective NEK1-D1277A did not. Wild-type C21ORF2 rescued its knockout, whereas an interaction-defective pathogenic C21ORF2 variant did not fully rescue. These experiments show that both NEK1 catalytic activity and NEK1–C21ORF2 complex formation are required for normal ciliogenesis. (gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 12-14)
Earlier work and recent reviews also connect NEK1 loss with centrosome instability, failure to form cilia, and abnormal branched cilia. The immediate ciliary substrate remains unknown, so the precise step—distal-appendage organization, axoneme initiation, microtubule stabilization, or ciliary trafficking—cannot yet be assigned exclusively. (baker2025nekfamilykinases pages 16-17)
NEK1 functions upstream of ATR–CHK1 checkpoint signaling. Reported mechanisms include TLK1-dependent NEK1-T141 phosphorylation, ATR–ATRIP stabilization/priming, ATR autophosphorylation, CHK1 activation, and enforcement of intra-S and G2/M checkpoints. NEK1 deficiency causes persistent γH2AX, defective arrest, chromosomal abnormalities, and impaired ATR/CHK1 responses after damage. (baker2025nekfamilykinases pages 12-13, baker2025nekfamilykinases pages 14-16, pavan2021onbrokenne(c)ks pages 5-7)
The 2023 study provides strong functional evidence for HR: depletion of either NEK1 or C21ORF2 markedly reduced gene conversion in Traffic-Light and DR-GFP reporters, with effects comparable to BRCA1 depletion. Baseline conversion frequencies were approximately 1.1% and 4%, respectively. Different cell-cycle effects of the two knockdowns argued against altered phase distribution as the sole cause. Nevertheless, the relevant phosphorylation substrate remains unidentified, and the new results challenge the earlier RAD54 model. (gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 9-12)
NEK1 also participates in responses to interstrand crosslinks: NEK1 depletion delayed FANCD2 monoubiquitination after cisplatin, while damage-dependent interactomics linked it to Fanconi-anemia, nucleotide-excision, mismatch-repair, and HR proteins. These interaction-network findings broaden the likely repair role but do not prove that every associated factor is a direct NEK1 substrate. (melohanchuk2017nek1kinasedomain pages 11-12)
Mann et al. (published August 2023) identified NEK1-associated proteins enriched for cytoskeletal homeostasis and nuclear transport. In day-40 human iPSC-derived spinal motor neurons, NEK1 siRNA reduced full-length protein by 50–60% across ten differentiations. Proteomics identified 15 interaction candidates and 28 differentially expressed proteins under the study’s consistency-based criteria; import receptors and microtubule-associated proteins were prominent. (mann2023lossoffunction pages 2-3)
NEK1 loss, kinase inhibition, and a patient mutation caused abnormal microtubule organization and nuclear-import defects. Two mechanistically distinct microtubule-stabilizing drug classes rescued both phenotypes, supporting a model in which altered microtubule dynamics contribute upstream to defective nucleocytoplasmic transport. α-Tubulin and importin-β1 phosphorylation provides a plausible molecular bridge, although endogenous phosphosite validation is still needed. (mann2023lossoffunction pages 2-3)
CRISPR NEK1-knockout HAP1 cells exhibited reduced mitophagy, increased mitochondrial abundance and reactive oxygen species, impaired complex-I activity, elevated mitochondrial-DNA damage, apoptosis, and altered transcription of DNA-repair genes. These results support a mitochondrial-homeostasis function but do not identify a single primary mitochondrial substrate; some effects could be secondary to chronic DNA damage or transcriptional adaptation. (baker2025nekfamilykinases pages 37-38, zelina2024alsassociatedc21orf2variant pages 31-32)
Heterozygous loss-of-function NEK1 variants are estimated to occur in approximately 2–3% of ALS cases, making NEK1 one of the more reproducible rare-variant ALS risk genes. Mechanistic evidence now converges on several connected abnormalities: DNA-damage accumulation, microtubule destabilization, impaired nuclear import, mitochondrial stress, and ciliary dysfunction. The relative causal weight of each pathway likely depends on cell type and variant. (baker2025nekfamilykinases pages 14-16, mann2023lossoffunction pages 2-3)
A 2024 patient-derived iPSC-motoneuron study found that NEK1 haploinsufficiency in a C9ORF72 background worsened DNA damage but did not further worsen the existing short-cilium phenotype. This argues against assuming that every NEK1-associated ALS context is driven principally by ciliogenesis and illustrates oligogenic/context-dependent effects. (santangelo2024nek1haploinsufficiencyworsens pages 7-8)
A separate September 2024 study showed that ALS-associated C21ORF2-V58L altered DNA repair, mitochondrial metabolism, neuronal excitability, and post-transcriptionally reduced NEK1 in human iPSC-derived motor neurons. This strengthens the biological connection between the two ALS genes but does not prove that all C21ORF2 phenotypes are mediated solely through NEK1. (zelina2024alsassociatedc21orf2variant pages 31-32)
Biallelic or severe NEK1 variants are associated with skeletal ciliopathy phenotypes, including short-rib thoracic dysplasia/short-rib polydactyly and axial spondylometaphyseal dysplasia. The failure of disease-associated C-terminal variants to maintain C21ORF2 binding and ciliogenesis offers a direct genotype-to-cellular-mechanism link. (gregorczyk2022interactionwithc21orf2 pages 12-14, gregorczyk2023functionalcharacterizationof pages 1-2)
Because NEK1 supports checkpoint signaling and repair, high NEK1 activity may allow tumor cells to survive radiation or DNA-crosslink damage. Conversely, constitutional loss causes genome instability. Experimental NEK1 depletion delayed repair signaling and sensitized cancer models to fractionated radiation, while structural work proposed the kinase domain as a starting point for inhibitor development. These are mechanistically plausible oncology applications, but NEK1’s normal roles in neurons, cilia, and genome maintenance create a substantial therapeutic-window concern. (baker2025nekfamilykinases pages 14-16, melohanchuk2017nek1kinasedomain pages 11-12)
No NEK1-selective drug has an established clinical application. Current implementations are research or preclinical:
The following table summarizes evidence strength and unresolved points.
| Functional module | Direct molecular evidence | Cellular location/model | Confidence / caveat | Key source, date, DOI URL |
|---|---|---|---|---|
| Kinase reaction and substrates | NEK1 is an ATP-dependent Ser/Thr protein kinase: ATP + protein-OH → ADP + phosphoprotein. Purified NEK1 phosphorylated α-tubulin and importin-β1 in vitro; kinase-dependent C21ORF2 phosphorylation is supported by a mobility shift. ATRIP-T1989 and RAD54-S572 have also been reported as targets. | Recombinant assays; HEK293FT cells; human iPSC-derived motor neurons; ARPE-19 cells | High for catalytic class; moderate for α-tubulin/importin-β1 because physiological sites and in-cell phosphorylation remain incompletely defined. C21ORF2 directness/site are unresolved. Disputed for RAD54: a 2023 study found neither NEK1-dependent RAD54 phosphorylation nor altered RAD51 loading/unloading. (pavan2021onbrokenne(c)ks pages 5-7, gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 9-12, mann2023lossoffunction pages 2-3) | Mann et al., August 2023, Science Advances; Gregorczyk et al., May 2023, Life Science Alliance; Pavan et al., February 2021, Cells |
| C21ORF2 regulatory complex | Endogenous NEK1 and C21ORF2 reciprocally co-immunoprecipitate and withstand 500 mM NaCl washes. The NEK1 acidic C-terminal interaction domain binds the C21ORF2 LRR region; NEK1-D1277A and charge-reversal interface mutations disrupt association. NEK1 depletion lowers C21ORF2 abundance. | Human ARPE-19, HeLa, HEK293 and U2OS cells; centrosome/ciliary context | High for a tight cellular complex and mapped interface; whether binding is direct is not fully resolved. The principal interface is strongly modeled and mutation-tested; a proposed second interface is low-confidence. (gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 9-12, gregorczyk2022interactionwithc21orf2 pages 4-7) | Gregorczyk et al., May 2023, Life Science Alliance |
| DNA-damage response and homologous recombination | NEK1 promotes ATR–ATRIP signaling, ATR autophosphorylation and CHK1-dependent checkpoints; TLK1 phosphorylation of NEK1-T141 increases NEK1 activity. NEK1 or C21ORF2 depletion markedly reduced HR in Traffic-Light and DR-GFP reporters, comparably to BRCA1 depletion. NEK1 depletion also delayed FANCD2 monoubiquitination after cisplatin. | Damage-induced γH2AX-positive nuclear foci; ARPE-19, HeLa and reporter-cell systems | High for a role in HR/DDR; the precise HR substrate remains unknown. Reporter baseline gene conversion was approximately 1.1% and 4%, respectively. Evidence does not sustain RAD54-S572 as a settled NEK1 substrate. (pavan2021onbrokenne(c)ks pages 5-7, melohanchuk2017nek1kinasedomain pages 11-12, gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 9-12) | Gregorczyk et al., May 2023, Life Science Alliance; Melo-Hanchuk et al., July 2017, Scientific Reports; Pavan et al., February 2021, Cells |
| Cilia and centrosomes | NEK1 or C21ORF2 knockout dramatically reduces serum-starvation-induced primary-cilium formation. Wild-type NEK1 rescues ciliogenesis, whereas kinase-dead D146A and C21ORF2-binding-defective D1277A do not; C21ORF2-L227P also fails to rescue fully. | Centrosome/basal-body and primary-cilium compartment; serum-starved human ARPE-19/RPE cells | High for requirements for NEK1 catalytic activity and C21ORF2 association. The relevant ciliary substrate(s) and exact recruitment mechanism remain unidentified. (baker2025nekfamilykinases pages 16-17, gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 12-14) | Gregorczyk et al., May 2023, Life Science Alliance |
| Microtubules and nuclear import | NEK1 interactomics enriched cytoskeletal and nuclear-import proteins; α-tubulin and importin-β1 were phosphorylated by NEK1 in vitro. NEK1 loss disrupted microtubule homeostasis and nuclear import, while two mechanistically distinct microtubule-stabilizing drug classes rescued both deficits. | Day-40 human iPSC-derived spinal motor neurons; HEK293FT cells; Drosophila validation | Moderate-to-high mechanistic evidence across models. In motor neurons, siRNA reduced NEK1 by 50–60% across 10 differentiations; proteomics identified 15 interactors and 28 differentially expressed proteins, but direct in-cell substrate-site validation is incomplete. (mann2023lossoffunction pages 2-3) | Mann et al., August 2023, Science Advances |
| Mitochondrial homeostasis | NEK1 knockout caused reduced mitophagy, increased mitochondrial mass and ROS, impaired respiratory-complex-I activity, increased mitochondrial-DNA damage and apoptosis. | CRISPR NEK1-knockout versus wild-type human HAP1 cells | Moderate: direct loss-of-function phenotypes support a regulatory role, but a mitochondrial substrate pathway was not established and some responses may be secondary to altered DDR/transcription. (baker2025nekfamilykinases pages 37-38, zelina2024alsassociatedc21orf2variant pages 31-32) | Martins et al., March 2021, Mutagenesis; Basei et al., March 2024, Cells |
| Translational status | NEK1 loss-of-function variants account for an estimated 2–3% of ALS cases. Preclinical strategies include restoring microtubule stability in NEK1-deficient motor neurons and inhibiting NEK1 to sensitize cancer cells to fractionated radiation or DNA-crosslinking therapy; kinase-domain structures support probe design. | Human iPSC motor neurons, cancer cell lines, three-dimensional clonogenic assays and mouse xenografts | Preclinical only: no validated NEK1-selective clinical drug or established NEK1-directed therapy. ALS may require restoration rather than inhibition, whereas oncology proposes inhibition—an important indication-specific distinction. (baker2025nekfamilykinases pages 14-16, melohanchuk2017nek1kinasedomain pages 11-12, mann2023lossoffunction pages 2-3) | Mann et al., August 2023, Science Advances; Freund et al., May 2020, Cells; Melo-Hanchuk et al., July 2017, Scientific Reports |
Table: Compact evidence map linking human NEK1 (Q96PY6) molecular activities to cellular compartments, disease mechanisms, and translational status. Confidence notes separate established functions from candidate or disputed substrate assignments.
The most defensible primary annotation is:
A multi-compartment serine/threonine protein kinase that, in a functional complex with C21ORF2, coordinates centrosome/primary-cilium formation and homologous-recombination-associated DNA-damage responses, and additionally regulates microtubule homeostasis and nucleocytoplasmic transport.
The evidence is strongest for the requirement for catalytic activity in ciliogenesis, for the physical/functional NEK1–C21ORF2 complex, and for loss-of-function effects on HR, microtubules, and nuclear import. By contrast, physiological substrate specificity remains the major annotation gap. α-Tubulin and importin-β1 are compelling direct candidates based on in-vitro phosphorylation and matching cellular phenotypes, but sites must be validated in cells. The precise HR and ciliary substrates remain unknown, C21ORF2 phosphorylation is incompletely mapped, and RAD54-S572 should not presently be presented as definitive. (gregorczyk2023functionalcharacterizationof pages 8-10, gregorczyk2022interactionwithc21orf2 pages 9-12, mann2023lossoffunction pages 2-3)
Thus, NEK1 should not be reduced to a generic “cell-cycle kinase.” Current data instead place it at an interface connecting ciliary microtubules, intracellular transport, DNA repair/checkpoints, and cellular stress resistance. This integrated model explains why partial loss can predispose to adult motor-neuron degeneration, whereas stronger biallelic disruption produces developmental skeletal ciliopathies; however, pathway dominance remains variant- and cell-context-dependent.
References
(gregorczyk2022interactionwithc21orf2 pages 4-7): Mateusz Gregorczyk, Graziana Pastore, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Daniel Durocher, and John Rouse. Interaction with c21orf2 controls the cellular functioning of the nek1 kinase. bioRxiv, Aug 2022. URL: https://doi.org/10.1101/2022.08.31.505651, doi:10.1101/2022.08.31.505651. This article has 0 citations.
(gregorczyk2023functionalcharacterizationof pages 2-3): Mateusz Gregorczyk, Graziana Pastore, Ivan Muñoz, Thomas Carroll, Johanna Streubel, Meagan Munro, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Gislene Pereira, Daniel Durocher, and John Rouse. Functional characterization of c21orf2 association with the nek1 kinase mutated in human in diseases. Life Science Alliance, 6:e202201740, May 2023. URL: https://doi.org/10.26508/lsa.202201740, doi:10.26508/lsa.202201740. This article has 26 citations and is from a peer-reviewed journal.
(gregorczyk2023functionalcharacterizationof pages 8-10): Mateusz Gregorczyk, Graziana Pastore, Ivan Muñoz, Thomas Carroll, Johanna Streubel, Meagan Munro, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Gislene Pereira, Daniel Durocher, and John Rouse. Functional characterization of c21orf2 association with the nek1 kinase mutated in human in diseases. Life Science Alliance, 6:e202201740, May 2023. URL: https://doi.org/10.26508/lsa.202201740, doi:10.26508/lsa.202201740. This article has 26 citations and is from a peer-reviewed journal.
(mann2023lossoffunction pages 2-3): Jacob R. Mann, Elizabeth D. McKenna, Darilang Mawrie, Vasileios Papakis, Francesco Alessandrini, Eric N. Anderson, Ryan Mayers, Hannah E. Ball, Evan Kaspi, Katherine Lubinski, Desiree M. Baron, Liana Tellez, John E. Landers, Udai B. Pandey, and Evangelos Kiskinis. Loss of function of the als-associated nek1 kinase disrupts microtubule homeostasis and nuclear import. Science Advances, Aug 2023. URL: https://doi.org/10.1126/sciadv.adi5548, doi:10.1126/sciadv.adi5548. This article has 46 citations and is from a highest quality peer-reviewed journal.
(gregorczyk2022interactionwithc21orf2 pages 12-14): Mateusz Gregorczyk, Graziana Pastore, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Daniel Durocher, and John Rouse. Interaction with c21orf2 controls the cellular functioning of the nek1 kinase. bioRxiv, Aug 2022. URL: https://doi.org/10.1101/2022.08.31.505651, doi:10.1101/2022.08.31.505651. This article has 0 citations.
(gregorczyk2022interactionwithc21orf2 pages 9-12): Mateusz Gregorczyk, Graziana Pastore, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Daniel Durocher, and John Rouse. Interaction with c21orf2 controls the cellular functioning of the nek1 kinase. bioRxiv, Aug 2022. URL: https://doi.org/10.1101/2022.08.31.505651, doi:10.1101/2022.08.31.505651. This article has 0 citations.
(baker2025nekfamilykinases pages 12-13): Brandon M. Baker, Julia R. Boehling, Sarah Knopf, Stephanie Held, Margarite Matossian, Jorge A. Belgodere, Van T. Hoang, Bridgette M. Collins-Burow, Elizabeth C. Martin, Sean B. Lee, Matthew E. Burow, David H. Drewry, and Robert H. Newman. Nek family kinases: structure, function, and role in disease. Biomolecules, 15(10):1406, Oct 2025. URL: https://doi.org/10.3390/biom15101406, doi:10.3390/biom15101406. This article has 7 citations.
(pavan2021onbrokenne(c)ks pages 5-7): Isadora Pavan, Andressa Peres de Oliveira, Pedro Dias, Fernanda Basei, Luidy Issayama, Camila Ferezin, Fernando Silva, Ana Rodrigues de Oliveira, Lívia Alves dos Reis Moura, Mariana Martins, Fernando Simabuco, and Jörg Kobarg. On broken ne(c)ks and broken dna: the role of human neks in the dna damage response. Cells, 10(3):507, Feb 2021. URL: https://doi.org/10.3390/cells10030507, doi:10.3390/cells10030507. This article has 50 citations.
(baker2025nekfamilykinases pages 16-17): Brandon M. Baker, Julia R. Boehling, Sarah Knopf, Stephanie Held, Margarite Matossian, Jorge A. Belgodere, Van T. Hoang, Bridgette M. Collins-Burow, Elizabeth C. Martin, Sean B. Lee, Matthew E. Burow, David H. Drewry, and Robert H. Newman. Nek family kinases: structure, function, and role in disease. Biomolecules, 15(10):1406, Oct 2025. URL: https://doi.org/10.3390/biom15101406, doi:10.3390/biom15101406. This article has 7 citations.
(gregorczyk2023functionalcharacterizationof pages 1-2): Mateusz Gregorczyk, Graziana Pastore, Ivan Muñoz, Thomas Carroll, Johanna Streubel, Meagan Munro, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Gislene Pereira, Daniel Durocher, and John Rouse. Functional characterization of c21orf2 association with the nek1 kinase mutated in human in diseases. Life Science Alliance, 6:e202201740, May 2023. URL: https://doi.org/10.26508/lsa.202201740, doi:10.26508/lsa.202201740. This article has 26 citations and is from a peer-reviewed journal.
(gregorczyk2022interactionwithc21orf2 pages 1-4): Mateusz Gregorczyk, Graziana Pastore, Pawel Lis, Sven Lange, Frederic Lamoliatte, Thomas Macartney, Rachel Toth, Fiona Brown, James Hastie, Daniel Durocher, and John Rouse. Interaction with c21orf2 controls the cellular functioning of the nek1 kinase. bioRxiv, Aug 2022. URL: https://doi.org/10.1101/2022.08.31.505651, doi:10.1101/2022.08.31.505651. This article has 0 citations.
(baker2025nekfamilykinases pages 14-16): Brandon M. Baker, Julia R. Boehling, Sarah Knopf, Stephanie Held, Margarite Matossian, Jorge A. Belgodere, Van T. Hoang, Bridgette M. Collins-Burow, Elizabeth C. Martin, Sean B. Lee, Matthew E. Burow, David H. Drewry, and Robert H. Newman. Nek family kinases: structure, function, and role in disease. Biomolecules, 15(10):1406, Oct 2025. URL: https://doi.org/10.3390/biom15101406, doi:10.3390/biom15101406. This article has 7 citations.
(melohanchuk2017nek1kinasedomain pages 11-12): Talita D. Melo-Hanchuk, Priscila Ferreira Slepicka, Gabriela Vaz Meirelles, Fernanda Luisa Basei, Diogo Ventura Lovato, Daniela Campos Granato, Bianca Alves Pauletti, Romenia Ramos Domingues, Adriana Franco Paes Leme, Alessandra Luiza Pelegrini, Guido Lenz, Stefan Knapp, Jonathan M. Elkins, and Jörg Kobarg. Nek1 kinase domain structure and its dynamic protein interactome after exposure to cisplatin. Scientific Reports, Jul 2017. URL: https://doi.org/10.1038/s41598-017-05325-w, doi:10.1038/s41598-017-05325-w. This article has 54 citations and is from a peer-reviewed journal.
(baker2025nekfamilykinases pages 37-38): Brandon M. Baker, Julia R. Boehling, Sarah Knopf, Stephanie Held, Margarite Matossian, Jorge A. Belgodere, Van T. Hoang, Bridgette M. Collins-Burow, Elizabeth C. Martin, Sean B. Lee, Matthew E. Burow, David H. Drewry, and Robert H. Newman. Nek family kinases: structure, function, and role in disease. Biomolecules, 15(10):1406, Oct 2025. URL: https://doi.org/10.3390/biom15101406, doi:10.3390/biom15101406. This article has 7 citations.
(zelina2024alsassociatedc21orf2variant pages 31-32): Pavol Zelina, Anna Aster de Ruiter, Christy Kolsteeg, Ilona van Ginneken, Harmjan R. Vos, Laura F. Supiot, Boudewijn M. T. Burgering, Frank J. Meye, Jan H. Veldink, Leonard H. van den Berg, and R. Jeroen Pasterkamp. Als-associated c21orf2 variant disrupts dna damage repair, mitochondrial metabolism, neuronal excitability and nek1 levels in human motor neurons. Acta Neuropathologica Communications, Sep 2024. URL: https://doi.org/10.1186/s40478-024-01852-6, doi:10.1186/s40478-024-01852-6. This article has 17 citations and is from a peer-reviewed journal.
(santangelo2024nek1haploinsufficiencyworsens pages 7-8): Serena Santangelo, Sabrina Invernizzi, Marta Nice Sorce, Valeria Casiraghi, Silvia Peverelli, Alberto Brusati, Claudia Colombrita, Nicola Ticozzi, Vincenzo Silani, Patrizia Bossolasco, and Antonia Ratti. Nek1 haploinsufficiency worsens dna damage, but not defective ciliogenesis, in c9orf72 patient-derived ipsc-motoneurons. Human Molecular Genetics, 33:1900-1907, Mar 2024. URL: https://doi.org/10.1101/2024.03.07.582752, doi:10.1101/2024.03.07.582752. This article has 10 citations and is from a domain leading peer-reviewed journal.